Atomik Labs is a research-peptide vendor that lists 74 injectable peptides and 7 capsules, including MOTS-c, Tesamorelin and Melanotan II. Across 68 products with a market median, its prices sit 5% above the median for the same peptide and vial size; it is the cheapest vendor we track on Semaglutide and MOTS-c, and pricier on Retatrutide. We found certificates for a few of the in-stock products we track. Based on the certificates our crawler found; vendors may publish more than we index.
Facts extracted from the vendor’s site and not yet reviewed by us.
COA coverage: Limited
We found certificates for a few of the in-stock products we track. Based on the certificates our crawler found; vendors may publish more than we index.
from 10 indexed documents
current certificates, by the date printed on them
Janoshik Analytical signs the most of them
oldest Sep 23, 2024
$8.57/mg median
▲ 32%
Median price per mg across Atomik Labs’s 11-83 priced listings, from Jul 17 ($6.50/mg) to Oct 14 ($8.57/mg) over 86 observed days. The mix of products behind the median changes as listings come and go, so this tracks the catalog as well as the prices.
11 of Atomik Labs’s tracked listings changed price in the last 30 days: 4 down, 7 up. Showing the 8 most recent.
Listed prices at Atomik Labs against the median price per mg for the same peptide at the same vial size, across every vendor we track. Vendors change prices without notice, so check the current listing before you order.
Below the market median on 17 of 44 comparable listings, above it on 23. Typical listing: 1% above market. Showing the 6 largest differences.
International
5% above
vs market median
56
peptides
Limited
in-stock products
Oct 14
International
8% above
vs market median
63
peptides
None found
in-stock products
Oct 14
International
18% below
vs market median
52
peptides
None found
in-stock products
Oct 14
International
3% above
vs market median
52
peptides
Partial
in-stock products
Oct 14
Atomik Labs sits 5% above market the tracked market median on matched peptide/size rows. The catalog in this index is smaller than Peptides Greyhouse's. On COA coverage, Atomik Labs rates limited and Peptides Greyhouse rates none found. Based on the certificates our crawler found; vendors may publish more than we index.
The honest comparison unit is price per mg on matched peptide/size rows. COA coverage is presence of a current indexed document, not purity-as-quality. See the Evidence Atlas and how to read a COA.
Evidence boundary: Listed prices, stock signals, and indexed COA documents are observations. They do not establish legitimacy, authenticity, safety, sterility, chain of custody, product quality, fulfillment, or suitability. No vendor is endorsed.
Pricing data cannot settle that question, and we do not test products or verify fulfillment. Here is the evidence we do hold for Atomik Labs. We found certificates for a few of the in-stock products we track. Those certificates were signed by 2 labs, the newest tested October 8, 2026. Based on the certificates our crawler found; vendors may publish more than we index. We have been recording their prices since July 3, 2026. Read each certificate yourself, check that its lot and compound match what you are buying, and treat anything we have not recorded as unknown rather than as an answer.
We found certificates for a few of the in-stock products we track. The freshest was tested October 8, 2026. Based on the certificates our crawler found; vendors may publish more than we index. We have not recorded a testing or COA page on their site. A certificate on file records what a document says; it cannot prove chain of custody or what is in the vial you receive.
We have none on record for Atomik Labs. When a code we can verify appears, it shows on this page and the prices here are adjusted for it; until then, every figure on this page is the list price.
Across 68 graded products, Atomik Labs's median price per mg sits 4.8% above the median for the same peptide at the same vial size. We track 56 products from them in total. Price per mg is the comparison unit: a cheaper vial holding less is not a cheaper product.
Product documentation
Across the tracked peptide products we hold for Atomik Labs, COA coverage rates limited. The public index contains 10 documents. Reported test dates in this set run from Sep 23, 2024 through Oct 8, 2026. That rating covers the full tracked catalogue for Atomik Labs, including products that are currently out of stock, so it can differ from the in-stock rating above. Based on the certificates our crawler found; vendors may publish more than we index.
across the full tracked catalogue
current certificates, by the printed test date.
Printed date is over 18 months old.
Named on more current records than any other lab.
Certificate assessment
4 evaluated certificates
3 graded · 1 not graded · 0 in the A range.
The sample prioritizes up to ten popular peptides from this vendor. Grades assess the document and its reported tests, not the vendor’s whole catalog or the safety of a product.
Automated checks can make mistakes. Open “Why this result?” for the reason and any review notice, and check the linked COA’s lot against your product. How grading works
4 evaluated records
Not graded
This looks like one part of a longer certificate (Footer shows "Page 1 of 2"), so it can't be graded on its own. Upload the full certificate of analysis for this batch.
Lab record: not confirmed.
Graded Oct 14, 2026 · Grader 0.4.9 · Policy 2026-10-07.2
RETA1126100
Document grade
X2: The certificate shows no identity test, so there is no evidence the vial contains the peptide on the label. Ask the vendor for a report that confirms identity by mass spectrometry.
Document check: fail.
Lab record: not confirmed.
Graded Oct 14, 2026 · Grader 0.4.9 · Policy 2026-10-07.2
011425FF
Document grade
X2: The certificate shows no identity test, so there is no evidence the vial contains the peptide on the label. Ask the vendor for a report that confirms identity by mass spectrometry.
Document check: fail.
Lab record: not confirmed.
Graded Oct 14, 2026 · Grader 0.4.9 · Policy 2026-10-07.2
FF1011
Document grade
X2: The certificate shows no identity test, so there is no evidence the vial contains the peptide on the label. Ask the vendor for a report that confirms identity by mass spectrometry.
Document check: fail.
Lab record: not confirmed.
Graded Oct 14, 2026 · Grader 0.4.9 · Policy 2026-10-07.2
FF0910
| COA grade | Printed lab | Certificate | |||
|---|---|---|---|---|---|
| Retatrutide Lot: RETA1126100 | Not graded Why this result?This looks like one part of a longer certificate (Footer shows "Page 1 of 2"), so it can't be graded on its own. Upload the full certificate of analysis for this batch. Lab record: not confirmed. Graded Oct 14, 2026 · Grader 0.4.9 · Policy 2026-10-07.2 | ILS Laboratories | Oct 8, 2026 | 99.47%99.0–99.49% | View COA |
| Tirzepatide Lot: 011425FF | Document grade Why this result?X2: The certificate shows no identity test, so there is no evidence the vial contains the peptide on the label. Ask the vendor for a report that confirms identity by mass spectrometry. Document check: fail. Lab record: not confirmed. Graded Oct 14, 2026 · Grader 0.4.9 · Policy 2026-10-07.2 | JANOSHIK | Jan 20, 2025Older record | 99.553%99.5%+ | View COA |
| Semaglutide Lot: FF1011 | Document grade Why this result?X2: The certificate shows no identity test, so there is no evidence the vial contains the peptide on the label. Ask the vendor for a report that confirms identity by mass spectrometry. Document check: fail. Lab record: not confirmed. Graded Oct 14, 2026 · Grader 0.4.9 · Policy 2026-10-07.2 | Janoshik | Oct 21, 2024Older record | 99.643%99.5%+ | View COA |
| Sermorelin Lot: FF0910 | Document grade Why this result?X2: The certificate shows no identity test, so there is no evidence the vial contains the peptide on the label. Ask the vendor for a report that confirms identity by mass spectrometry. Document check: fail. Lab record: not confirmed. Graded Oct 14, 2026 · Grader 0.4.9 · Policy 2026-10-07.2 | Janoshik | Sep 23, 2024Older record | 99.181%99.0–99.49% | View COA |
4 current records
RETA1126100
011425FF
FF1011
FF0910
| Printed lab | Certificate | |||
|---|---|---|---|---|
| Retatrutide | ILS Laboratories | Oct 8, 2026 | 99.47%99.0–99.49% | View COA |
| Tirzepatide | JANOSHIK | Jan 20, 2025Older record | 99.553%99.5%+ | View COA |
| Semaglutide | Janoshik | Oct 21, 2024Older record | 99.643%99.5%+ | View COA |
| Sermorelin | Janoshik | Sep 23, 2024Older record | 99.181%99.0–99.49% | View COA |
A record appears on file after our pipeline identifies the document as a certificate of analysis and matches its printed compound to a catalog peptide. The record cannot prove authenticity, chain of custody, sterility, product safety, or suitability for use.
These are counts of documents in our index, and a coverage rating of what our crawler found. They do not grade vendor quality, legitimacy, or safety. Printed fields can contain transcription errors. “Older record” means the reported test date is more than 18 months old.
See the testing methodology and dataset, or compare this coverage against another vendor in the vendor comparison tool.
The Peptide App. Atomik Labs peptide prices, COA coverage and vendor facts. Updated October 14, 2026. https://www.thepeptide.app/pricing/vendor/atomik-labs
The Peptide App. (2026). Atomik Labs peptide prices, COA coverage and vendor facts. Retrieved from https://www.thepeptide.app/pricing/vendor/atomik-labs
Prices and certificate counts on this page were last refreshed October 14, 2026.
